Hair-loss products: cosmetic or drug? Where the line sits
Where a hair loss shampoo stops being a cosmetic: claim wording that is safe, borderline or a drug claim in the EU, GB, US, India and Saudi Arabia.
Read article
Insights · Regulations
Rule changes and what they mean for your products, market by market: EU, UK, US, Canada, GCC, ASEAN, India and ANZ.
148 articles
No articles in this selection yet. The first pieces in this category are on the way: subscribe to hear when they are published, or ask the CSL team and we may write it next.
Where a hair loss shampoo stops being a cosmetic: claim wording that is safe, borderline or a drug claim in the EU, GB, US, India and Saudi Arabia.
Read articleHow the EU, UK, US, India and GCC regulate preservatives, the traps in Annex V and the deadlines to watch.
Read articleWhat the EU Regulation requires from a safety assessment, how the report is built and which stability data an assessor will ask for.
Read articleWhat the Cosmetics Rules, 2020 require of a formula: licences, import registration, IS 4707 ingredient lists, labelling, claims and the 2025 changes.
Read articleHow the US sunscreen filter backlog formed, why bemotrizinol’s June 2026 final order matters, and the route a sunscreen must follow in the EU, UK, US, India and GCC.
Read articleWho can act as the Responsible Person, what the Product Information File must hold, the UK SCPN route, and how the US, India and the GCC compare.
Read articleAnalysing a cosmetic you bought is generally lawful in the EU, UK, US and UAE; copying patents or brands is not. The rules by market, plus a freedom-to-operate checklist.
Read articleISO 22716 clause by clause: the evidence auditors ask for, how EU Article 8 and MoCRA reference it, and five steps to qualify a contract manufacturer.
Read articleThe EU PFHxA limits now apply to cosmetics. What fluorochemistry did in long-wear and sun formulas, what replaces it, and how to prove the new formula works in Gulf heat.
Read articleFacility registration, product listing, US Agent, safety substantiation and adverse event reporting, in the order to tackle them.
Read articleBuilding a filter system accepted in the EU, US, Australia and ASEAN.
Read articleHow UAE authorities classify high-performance skin care, and how claim wording decides the route.
Read articleCategories
Ten themes, written by our formulation, regulatory, testing and product teams. Pick one to see its articles.
Regulatory watch newsletter
A monthly email on new ingredient restrictions, MoCRA updates and market deadlines. Plus our free guides and webinar invitations.
Start a project
Our formulation chemists, testing scientists and regulatory specialists work alongside your team, from the first brief to a market-ready product. Bring a brief, a benchmark or just an idea: a scientist will reply within one working day with next steps and an indicative scope.